<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02585739</url>
  </required_header>
  <id_info>
    <org_study_id>2011-19</org_study_id>
    <secondary_id>RC12_3011</secondary_id>
    <nct_id>NCT02585739</nct_id>
  </id_info>
  <brief_title>Cluster Headache and SPINK-1 Gene</brief_title>
  <official_title>Cluster Headache and SPINK-1 Gene</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <brief_summary>
    <textblock>
      Cluster headache (CH) is a rare, excruciating primary headache disorder. A genetic basis has
      been suggested by family and twin studies, but the mode of transmission seems to vary and the
      amount of heritability is unclear.

      The number of genetic association studies investigating variants implicated in the
      pathophysiology of CH is limited. The HCRTR2 1246G &gt; A and the ADH4 925A &gt; G polymorphisms
      have been associated with CH. The former has been confirmed and may affect the hypothalamic
      hypocretin system. The aim of the present study was to investigate the possible link between
      SPINK 1 gene and cluster headache.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SPINK1 genotyping</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Episodic or Chronic Cluster Headache</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient with Cluster headache</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy subject</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patient without Cluster headache</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>patient</arm_group_label>
    <arm_group_label>healthy subject</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  People aged 18 or over

          -  Patient consulting in Marseille's or Nice's Pain departments

          -  Patient agreeing to participate to the research study

          -  Patient with health insurance

        Exclusion Criteria:

          -  People aged under 18

          -  Patient refusing to participate to the research study

          -  Patient with deprivation of liberty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>urielle desalbres</last_name>
    <role>Study Director</role>
    <affiliation>APHM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>APHM</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 22, 2015</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2015</study_first_posted>
  <last_update_submitted>October 22, 2015</last_update_submitted>
  <last_update_submitted_qc>October 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Cluster Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

